The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) Study
Launched by LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE · Oct 20, 2005
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
Background : While there is a high level of knowledge on HIV/AIDS in rural South Africa, structural factors, including poverty and gender inequalities, have critically impeded prevention efforts based on modifying individual risk. Attempts to rigorously evaluate structural interventions for the prevention of HIV infection in sub-Saharan Africa remain under-developed.
Microfinance is a well-established development tool with nearly 100 million clients world wide. Loans to poor households, particularly to women, facilitate business development opportunities. Prior research has demonstrated si...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cohort I (Intervention community) : Joining the IMAGE programme
- • Cohort I (Comparison community) : Female, Eligible to receive microfinance loan and residing in an IMAGE Comparison community, matched on community pair and age group (18-25, 26-35, 36-45, 46-55, 56+) to the index IMAGE participant.
- • Cohort II (Intervention community) : 14-35 years old at time of interview. Current residence in the household of a woman who joins the IMAGE programme.
- • Cohort II (Comparison community) : 14-35 years old at time of interview. Current residence in the household of the non-IMAGE participant selected for inclusion in Cohort I.
- • Cohort III (Intervention community) : 14-35 years old at time of interview, Household member in a community where IMAGE is operating.
- • Cohort III (Comparison community) : 14-35 years old at time of interview. Household member in an IMAGE study community where IMAGE is not operating.
- Exclusion Criteria:
- • Lack of informed consent
About London School Of Hygiene And Tropical Medicine
The London School of Hygiene and Tropical Medicine (LSHTM) is a prestigious research institution renowned for its leadership in global health and infectious disease research. Committed to advancing public health through innovative research and education, LSHTM conducts a wide array of clinical trials aimed at improving health outcomes in diverse populations. With a multidisciplinary team of experts, LSHTM leverages cutting-edge methodologies and collaborative partnerships to address pressing health challenges, particularly in low- and middle-income countries. The institution's dedication to evidence-based solutions underscores its pivotal role in shaping health policies and practices worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tzaneen, Limpopo Province, South Africa
Patients applied
Trial Officials
Paul M Pronyk, MD
Principal Investigator
London School of Hygiene and Tropical Medicine, UK & Rural AIDS and Development Action Research Programme, University of the Witwatersrand, South Africa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials